Caribou Biosciences (CRBU) Cash from Investing Activities Growth (1y) (2021 - 2026)
Caribou Biosciences (CRBU) Cash from Investing Activities Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 62.68% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -674.01% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -166.24% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Caribou Biosciences | 152.90 Mn | 35.27 Mn | - | -51.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -51.43% |
| Dec 31, 2025 | 12.81% |
| Sep 30, 2025 | -59.09% |
| Jun 30, 2025 | 13.38% |
| Mar 31, 2025 | 115.11% |
| Dec 31, 2024 | 150.61% |
| Sep 30, 2024 | 138.73% |
| Jun 30, 2024 | 91.61% |
| Mar 31, 2024 | 10.88% |
| Dec 31, 2023 | -2,790.09% |
| Sep 30, 2023 | -721.15% |
| Jun 30, 2023 | 179.18% |
| Mar 31, 2023 | 128.71% |
| Dec 31, 2022 | 100.67% |
| Sep 30, 2022 | -332.07% |
| Jun 30, 2022 | -2,786.98% |
| Mar 31, 2022 | -327,659.09% |
| Dec 31, 2021 | -28,893.50% |
| Sep 30, 2021 | -48,150.00% |